Chapter 9 examines the real-time barriers to public health response that middle-income country demands caused in the context of Zika and MERS-CoV The authors identify difficulties in identifying countries that possessed relevant biological samples and data, protracted negotiations over location, collaboration, and benefit sharing of research, and the development of standard agreements afterward that aimed at reducing transaction costs for access to crucial research inputs This chapter drives home the implications of the changing system of pathogen sharing for US national security